
biote Corp. Stock Analysis & AI Score
biote Corp. (BTMD) has an ST Score of 55.5 (B-), driven by its Forecast (A) and held back by its Momentum (F). Analysts rate it Buy with a $4.00 price target (+225.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
biote Corp. (BTMD) has an ST Score of 55.5 (B-), driven by its Forecast (A) and held back by its Momentum (F). Analysts rate it Buy with a $4.00 price target (+225.2% upside).
- Strongest
- ForecastA
- Weakest
- MomentumF
All factor grades
- ForecastA
- ValuationA-
- ProfitabilityB
- Financial StrengthC
- GrowthC-
- MomentumF
- Piotroski7/9
Contact
BTMD stock: frequently asked questions
What is BTMD's ST Score?
biote Corp. (BTMD) has an ST Score of 55.5 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BTMD a buy, hold, or sell?
Analysts rate BTMD a Buy, with a price target of $4.00 (+225.2% vs the current price). Our ST Score grades it B- (55.5/100). The ST Score is a data-driven signal, not a recommendation.
What are BTMD's factor grades?
Valuation A-, Profitability B, Financial Strength C, Momentum F, Growth C-, Forecast A.
What is BTMD's valuation grade?
biote Corp. (BTMD) earns a valuation grade of A-, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BTMD's growth grade?
biote Corp. (BTMD) earns a growth grade of C-, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BTMD's profitability grade?
biote Corp. (BTMD) earns a profitability grade of B, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BTMD's financial strength grade?
biote Corp. (BTMD) earns a financial strength grade of C, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BTMD?
The average analyst price target for biote Corp. (BTMD) is $4.00 from 7 analysts, which is +225.2% versus the recent price of $1.23.
What is BTMD's Piotroski score?
biote Corp. (BTMD) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.